Mustang Bio MBIO

$ 0.23 -3.73%

Quarterly report 2024-Q2
added 08-13-2024

Mustang Bio Balance Sheet 2011-2024 | MBIO

Annual Balance Sheet Mustang Bio

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-3.74 M	-71.7 M	-108 M	-95.6 M	-48 M	-16.5 M	-35 M	-27.2 M	3.57 M	-	-	-	-
Long Term Debt	1.98 M	3.33 M	1.68 M	-	12.2 M	-	-	-	-	-	-	-	-
Long Term Debt Current	520 K	612 K	348 K	278 K	257 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	1.95 M	14 M	741 K	50 K	-	-	-	-	-	-
Total Current Liabilities	15.4 M	15.1 M	10.8 M	9.52 M	7.77 M	5.62 M	3.61 M	3.22 M	-	-	-	-	-
Total Liabilities	17.6 M	46.1 M	12.8 M	11.5 M	21.8 M	6.36 M	3.66 M	3.22 M	4.13 M	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-381 M	-329 M	-252 M	-185 M	-125 M	-79.1 M	-48.4 M	-17.1 M	-4.47 M	-	-	-	-
Total Assets	17.7 M	92.4 M	125 M	110 M	73.4 M	42.8 M	63.5 M	27.5 M	-	-	-	-	-
Cash and Cash Equivalents	6.23 M	75.7 M	110 M	97.8 M	61.4 M	17 M	35.5 M	27.5 M	-	-	-	-	-
Book Value	123 K	46.3 M	112 M	98.4 M	51.7 M	36.4 M	59.8 M	24.3 M	-4.13 M	-	-	-	-
Total Shareholders Equity	123 K	46.3 M	112 M	98.4 M	51.7 M	36.4 M	59.8 M	24.3 M	-4.13 M	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Mustang Bio

	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	656 K	1.83 M	2.12 M	2.24 M	3.28 M	3.33 M	3.39 M	1.5 M	1.59 M	1.68 M	1.76 M	1.82 M	1.88 M	1.95 M	1.95 M	1.95 M	1.95 M	1.84 M	1.84 M	1.84 M	1.91 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	16.8 M	19.5 M	16.6 M	15.4 M	43.8 M	46.1 M	44.5 M	39.9 M	39.6 M	12.8 M	12.5 M	8.18 M	8.46 M	11.5 M	11.5 M	11.5 M	11.5 M	21.8 M	21.8 M	21.8 M	22 M	6.36 M	6.36 M	6.36 M	6.36 M	3.66 M	3.66 M	3.66 M	3.66 M	3.22 M	3.22 M	3.22 M	3.22 M	4.13 M	4.13 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-394 M	-386 M	-372 M	-362 M	-346 M	-329 M	-310 M	-291 M	-272 M	-252 M	-232 M	-215 M	-200 M	-185 M	-185 M	-185 M	-185 M	-125 M	-125 M	-125 M	-88.7 M	-79.1 M	-79.1 M	-79.1 M	-79.1 M	-48.4 M	-48.4 M	-48.4 M	-48.4 M	-17.1 M	-17.1 M	-17.1 M	-17.1 M	-4.47 M	-4.47 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	8.52 M	14.6 M	20.6 M	29.1 M	73.6 M	92.4 M	109 M	122 M	137 M	125 M	135 M	143 M	142 M	110 M	110 M	110 M	110 M	73.4 M	73.4 M	73.4 M	50.5 M	42.8 M	42.8 M	42.8 M	42.8 M	63.5 M	63.5 M	63.5 M	63.5 M	27.5 M	27.5 M	27.5 M	27.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	4.27 M	1.34 M	9.56 M	15.4 M	58.1 M	75.7 M	91.4 M	107 M	122 M	110 M	121 M	130 M	129 M	97.8 M	97.8 M	97.8 M	97.8 M	61.4 M	61.4 M	61.4 M	36.1 M	16.5 M	16.5 M	17 M	17 M	35.5 M	33.2 M	53.8 M	75 M	27.5 M	11.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-8.33 M	-4.94 M	4.01 M	13.7 M	29.8 M	46.3 M	64.3 M	82 M	97.3 M	112 M	122 M	135 M	133 M	98.4 M	98.4 M	98.4 M	98.4 M	51.7 M	51.7 M	51.7 M	28.5 M	36.4 M	36.4 M	36.4 M	36.4 M	59.8 M	59.8 M	59.8 M	59.8 M	24.3 M	24.3 M	24.3 M	24.3 M	-4.13 M	-4.13 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-8.33 M	-4.94 M	4.01 M	13.7 M	29.8 M	46.3 M	64.3 M	82 M	97.3 M	112 M	122 M	135 M	133 M	98.4 M	98.4 M	98.4 M	98.4 M	51.7 M	51.7 M	51.7 M	28.5 M	36.4 M	36.4 M	36.4 M	36.4 M	59.8 M	59.8 M	59.8 M	59.8 M	24.3 M	24.3 M	24.3 M	24.3 M	-4.13 M	-4.13 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency